Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies.
Kelsey A FletcherMai H AlkurashiAndrew J LindsayPublished in: Breast cancer research and treatment (2024)
Our data suggest that combining ERIs with hormone receptor antagonists may enhance their efficacy and reduce the emergence of drug resistance.